News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
534,605 Results
Type
Article (31031)
Company Profile (378)
Press Release (503196)
Multimedia
Podcasts (80)
Webinars (9)
Section
Business (154499)
Career Advice (1450)
Deals (28125)
Drug Delivery (81)
Drug Development (74487)
Employer Resources (124)
FDA (12685)
Job Trends (10718)
News (269635)
Policy (22258)
Tag
Academia (1884)
Academic (1)
Accelerated approval (7)
Adcomms (26)
Allergies (79)
Alliances (38092)
ALS (97)
Alzheimer's disease (1333)
Antibody-drug conjugate (ADC) (145)
Approvals (12684)
Artificial intelligence (209)
Autoimmune disease (24)
Automation (11)
Bankruptcy (235)
Best Places to Work (8890)
BIOSECURE Act (15)
Biosimilars (77)
Biotechnology (297)
Bladder cancer (80)
Brain cancer (31)
Breast cancer (291)
Cancer (2295)
Cardiovascular disease (186)
Career advice (1221)
Career pathing (27)
CAR-T (185)
Cell therapy (509)
Cervical cancer (16)
Clinical research (61085)
Collaboration (823)
Company closure (1)
Compensation (543)
Complete response letters (23)
COVID-19 (1946)
CRISPR (51)
C-suite (244)
Cystic fibrosis (106)
Data (2298)
Decentralized trials (1)
Denatured (18)
Depression (49)
Diabetes (248)
Diagnostics (4471)
Digital health (14)
Diversity (3)
Diversity, equity & inclusion (31)
Drug discovery (117)
Drug pricing (88)
Drug shortages (23)
Duchenne muscular dystrophy (106)
Earnings (64734)
Editorial (35)
Employer branding (18)
Employer resources (110)
Events (89895)
Executive appointments (696)
FDA (13911)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (711)
Gene editing (119)
Generative AI (19)
Gene therapy (377)
GLP-1 (686)
Government (2707)
Grass and pollen (4)
Guidances (147)
Healthcare (14091)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (135)
Indications (29)
Infectious disease (2053)
Inflammatory bowel disease (147)
Inflation Reduction Act (12)
Influenza (35)
Intellectual property (94)
Interviews (248)
IPO (14263)
IRA (31)
Job creations (2243)
Job search strategy (1053)
Kidney cancer (10)
Labor market (32)
Layoffs (391)
Leadership (14)
Legal (4588)
Liver cancer (70)
Lung cancer (319)
Lymphoma (162)
Machine learning (7)
Management (42)
Manufacturing (287)
MASH (84)
Medical device (8939)
Medtech (8943)
Mergers & acquisitions (14442)
Metabolic disorders (693)
Multiple sclerosis (79)
NASH (20)
Neurodegenerative disease (106)
Neuropsychiatric disorders (32)
Neuroscience (1909)
NextGen: Class of 2025 (4592)
Non-profit (2562)
Now hiring (31)
Obesity (367)
Opinion (212)
Ovarian cancer (77)
Pain (90)
Pancreatic cancer (77)
Parkinson's disease (160)
Partnered (19)
Patents (217)
Patient recruitment (113)
Peanut (45)
People (45683)
Pharmaceutical (73)
Pharmacy benefit managers (24)
Phase I (19412)
Phase II (27244)
Phase III (19994)
Pipeline (1408)
Policy (124)
Postmarket research (2068)
Preclinical (8009)
Press Release (71)
Prostate cancer (108)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (414)
Real estate (3813)
Recruiting (48)
Regulatory (16854)
Reports (29)
Research institute (1876)
Resumes & cover letters (205)
Rett syndrome (6)
RNA editing (7)
RSV (23)
Schizophrenia (77)
Series A (126)
Series B (89)
Service/supplier (5)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (150)
Sponsored (26)
Startups (2890)
State (1)
Stomach cancer (15)
Supply chain (53)
Tariffs (29)
The Weekly (61)
Vaccines (455)
Venture capitalists (41)
Weight loss (236)
Women's health (24)
Worklife (15)
Date
Today (191)
Last 7 days (887)
Last 30 days (3229)
Last 365 days (29703)
2025 (11483)
2024 (32027)
2023 (35896)
2022 (45173)
2021 (48239)
2020 (44052)
2019 (34260)
2018 (25856)
2017 (26296)
2016 (24419)
2015 (29022)
2014 (22281)
2013 (17693)
2012 (18422)
2011 (19103)
2010 (18128)
Location
Africa (520)
Alabama (53)
Alaska (5)
Arizona (143)
Arkansas (8)
Asia (30814)
Australia (5251)
California (6019)
Canada (1851)
China (519)
Colorado (219)
Connecticut (257)
Delaware (156)
Europe (70972)
Florida (824)
Georgia (190)
Idaho (39)
Illinois (458)
India (25)
Indiana (246)
Iowa (7)
Japan (167)
Kansas (84)
Kentucky (24)
Louisiana (12)
Maine (52)
Maryland (728)
Massachusetts (4750)
Michigan (183)
Minnesota (359)
Mississippi (2)
Missouri (75)
Montana (24)
Nebraska (18)
Nevada (54)
New Hampshire (48)
New Jersey (1671)
New Mexico (19)
New York (1594)
North Carolina (960)
North Dakota (9)
Northern California (2662)
Ohio (187)
Oklahoma (13)
Oregon (28)
Pennsylvania (1295)
Puerto Rico (7)
Rhode Island (29)
South America (758)
South Carolina (20)
Southern California (2259)
Tennessee (82)
Texas (824)
United States (22026)
Utah (143)
Virginia (137)
Washington D.C. (52)
Washington State (567)
West Virginia (2)
Wisconsin (54)
534,605 Results for "ther rx corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Optum Rx Further Simplifies Consumer Access to Prescription Drugs
March 19, 2025
·
2 min read
Earnings
BridgeBio Stock Hits 1-Year High as Attruby Rx Numbers Double
BridgeBio beat investor expectations with 1,028 unique prescriptions for ATTR-CM therapy Attruby, setting the company up to beat a 2025 sales consensus of $86 million.
February 20, 2025
·
2 min read
·
Annalee Armstrong
Business
Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance
Prime Therapeutics LLC/Magellan Rx Management, LLC (Prime), a leading pharmacy solutions organization, and Capital Rx, Inc. (Capital Rx), a renowned health care technology solutions provider, are announcing a strategic alliance.
March 13, 2024
·
4 min read
Press Releases
Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches
May 1, 2025
·
8 min read
Press Releases
Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications
March 21, 2025
·
7 min read
Press Releases
GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement
March 17, 2025
·
4 min read
BioMidwest
Prime Therapeutics and Magellan Rx present award-winning and industry-leading clinical insights at AMCP
Prime Therapeutics LLC / Magellan Rx Management, LLC continues to publish award-winning and industry-leading research on a range of clinical topics impacting the health care and pharmacy benefit management industry. Thought leaders from Prime/MRx will present eight research studies at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, April 15-18 in New Orleans.
April 11, 2024
·
3 min read
Business
Aranscia and Signature RX Announce Personalized Medication Management Program for GLP-1s
Aranscia, a leading provider of personalized diagnostic solutions, and Signature RX, a leading pharmacy supplier and 503B manufacturer, announced a partnership to develop novel biomarkers and a personalized medication management solution for the effective use of GLP-1 medications.
June 20, 2024
·
4 min read
Business
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
Petros Pharmaceuticals, Inc. announces it has formed an Advisory Committee to provide guidance as the company prepares for the potential Rx-to-OTC switch for STENDRA for both development and communication with the U.S. Food and Drug Administration.
May 21, 2024
·
9 min read
Press Releases
Pharma Logistics, LLC and Rx Reverse Distributors, Inc. Unite, Setting a New Standard in Pharmaceutical Reverse Distribution
January 6, 2025
·
3 min read
1 of 53,461
Next
